Literature DB >> 27647852

Patterns of Estimated Glomerular Filtration Rate Decline Leading to End-Stage Renal Disease in Type 1 Diabetes.

Jan Skupien1,2,3, James H Warram4,2, Adam M Smiles4,2, Robert C Stanton4,2,5, Andrzej S Krolewski1,2.   

Abstract

OBJECTIVE: The patterns of estimated glomerular filtration rate (eGFR) decline to end-stage renal disease (ESRD) in patients with type 1 diabetes has not been conclusively described. Decline could be linearly progressive to ESRD but with a variable rate. Conversely, decline may be linear but interrupted by periods of plateaus or improvements. RESEARCH DESIGN AND METHODS: This observational study included 364 patients with type 1 diabetes attending the Joslin Clinic who developed ESRD between 1991 and 2013. We retrieved serum creatinine measurements from clinic visits or research examinations up to 24 years (median 6.7 years) preceding the onset of ESRD. Using serial measurements of serum creatinine to estimate renal function (eGFR), we used regression-based spline methods and a data smoothing approach to characterize individual trajectories of eGFR over time for the 257 patients with five or more data points.
RESULTS: The rate of eGFR decline per year ranged widely, from -72 to -2 mL/min/1.73 m2 (median -8.5). The trajectories, as characterized with linear regression-based spline models, were linear or nearly so for 87% of patients, accelerating for 6%, and decelerating for 7%. Smoothed trajectories evaluated by a Bayesian approach did not significantly depart from a linear fit in 76%.
CONCLUSIONS: The decline of eGFR in type 1 diabetes is predominantly linear. Deviations from linearity are small, with little effect on the expected time of ESRD. A single disease process most likely underlies renal decline from its initiation and continues with the same intensity to ESRD. Linearity of renal decline suggests using slope reduction as the measure of effectiveness of interventions to postpone ESRD.
© 2016 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2016        PMID: 27647852      PMCID: PMC5127236          DOI: 10.2337/dc16-0950

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  38 in total

1.  A reciprocal graph to plot the reciprocal serum creatinine over time.

Authors:  A J Bleyer
Journal:  Am J Kidney Dis       Date:  1999-09       Impact factor: 8.860

2.  Progression of nephropathy in long-term diabetics with proteinuria and effect of initial anti-hypertensive treatment.

Authors:  C E Mogensen
Journal:  Scand J Clin Lab Invest       Date:  1976-07       Impact factor: 1.713

3.  Risk for ESRD in type 1 diabetes remains high despite renoprotection.

Authors:  Elizabeth T Rosolowsky; Jan Skupien; Adam M Smiles; Monika Niewczas; Bijan Roshan; Robert Stanton; John H Eckfeldt; James H Warram; Andrzej S Krolewski
Journal:  J Am Soc Nephrol       Date:  2011-02-25       Impact factor: 10.121

4.  Do all prepubertal years of diabetes duration contribute equally to diabetes complications?

Authors:  Kim C Donaghue; Jan M Fairchild; Maria E Craig; Albert K Chan; Stephen Hing; Lucy R Cutler; Neville J Howard; Martin Silink
Journal:  Diabetes Care       Date:  2003-04       Impact factor: 19.112

5.  Incidence of ESRD and survival after renal replacement therapy in patients with type 1 diabetes: a report from the Allegheny County Registry.

Authors:  Rimei Nishimura; Janice S Dorman; Zsolt Bosnyak; Naoko Tajima; Dorothy J Becker; Trevor J Orchard
Journal:  Am J Kidney Dis       Date:  2003-07       Impact factor: 8.860

6.  Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes.

Authors:  S P Laing; A J Swerdlow; S D Slater; A C Burden; A Morris; N R Waugh; W Gatling; P J Bingley; C C Patterson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

7.  Monitoring glomerular function in diabetic nephropathy. A prospective study.

Authors:  G C Viberti; R W Bilous; D Mackintosh; H Keen
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

Review 8.  Diabetic Nephropathy and CKD-Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and Prediction.

Authors:  Macaulay Amechi Chukwukadibia Onuigbo; Nneoma Agbasi
Journal:  J Clin Med       Date:  2015-06-26       Impact factor: 4.241

9.  Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes.

Authors:  Linda H Ficociello; Bruce A Perkins; Bijan Roshan; Janice M Weinberg; Ann Aschengrau; James H Warram; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2009-02-05       Impact factor: 19.112

10.  Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria.

Authors:  Andrzej S Krolewski; Monika A Niewczas; Jan Skupien; Tomhito Gohda; Adam Smiles; Jon H Eckfeldt; Alessandro Doria; James H Warram
Journal:  Diabetes Care       Date:  2013-08-12       Impact factor: 19.112

View more
  15 in total

Review 1.  Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.

Authors:  Andrzej S Krolewski; Jan Skupien; Peter Rossing; James H Warram
Journal:  Kidney Int       Date:  2017-03-31       Impact factor: 10.612

2.  Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.

Authors:  Masayuki Yamanouchi; Jan Skupien; Monika A Niewczas; Adam M Smiles; Alessandro Doria; Robert C Stanton; Andrzej T Galecki; Kevin L Duffin; Nick Pullen; Matthew D Breyer; Joseph V Bonventre; James H Warram; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2017-04-07       Impact factor: 10.612

3.  Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.

Authors:  Natalia Nowak; Jan Skupien; Adam M Smiles; Masayuki Yamanouchi; Monika A Niewczas; Andrzej T Galecki; Kevin L Duffin; Matthew D Breyer; Nick Pullen; Joseph V Bonventre; Andrzej S Krolewski
Journal:  Kidney Int       Date:  2018-02-02       Impact factor: 10.612

4.  Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.

Authors:  Monika A Niewczas; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2017-08       Impact factor: 19.112

5.  The effect of model selection on cost-effectiveness research: a comparison of kidney function-based microsimulation and disease grade-based microsimulation in chronic kidney disease modeling.

Authors:  Shusuke Hiragi; Hiroshi Tamura; Rei Goto; Tomohiro Kuroda
Journal:  BMC Med Inform Decis Mak       Date:  2018-11-09       Impact factor: 2.796

6.  Risk Factors Associated With the Development of Nephropathy 10 Years After Diagnosis in Taiwanese Children With Juvenile-Onset Type 1 Diabetes-A Cohort Study From the CGJDES.

Authors:  Ching-Chien Yang; Chia-Hung Lin; Nan-Kai Wang; Chi-Chun Lai; Fu-Sung Lo
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-03       Impact factor: 5.555

Review 7.  Biomarkers of diabetic kidney disease.

Authors:  Helen M Colhoun; M Loredana Marcovecchio
Journal:  Diabetologia       Date:  2018-03-08       Impact factor: 10.122

8.  Biomarker panels associated with progression of renal disease in type 1 diabetes.

Authors:  Marco Colombo; Erkka Valo; Stuart J McGurnaghan; Niina Sandholm; Luke A K Blackbourn; R Neil Dalton; David Dunger; Per-Henrik Groop; Paul M McKeigue; Carol Forsblom; Helen M Colhoun
Journal:  Diabetologia       Date:  2019-06-20       Impact factor: 10.122

9.  Decline of kidney function during the pre-dialysis period in chronic kidney disease patients: a systematic review and meta-analysis.

Authors:  Cynthia J Janmaat; Merel van Diepen; Cheyenne Ce van Hagen; Joris I Rotmans; Friedo W Dekker; Olaf M Dekkers
Journal:  Clin Epidemiol       Date:  2018-05-25       Impact factor: 4.790

10.  Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.

Authors:  Jan Skupien; Adam M Smiles; Erkka Valo; Tarunveer S Ahluwalia; Beata Gyorgy; Niina Sandholm; Stephanie Croall; Maria Lajer; Kevin McDonnell; Carol Forsblom; Valma Harjutsalo; Michel Marre; Andrzej T Galecki; David-Alexandre Tregouet; Chun Yi Wu; Josyf C Mychaleckyj; Helen Nickerson; Marlon Pragnell; Stephen S Rich; Marcus G Pezzolesi; Samy Hadjadj; Peter Rossing; Per-Henrik Groop; Andrzej S Krolewski
Journal:  Diabetes Care       Date:  2018-11-19       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.